Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sendero Biotechnology
AddedFeb 15, 2024
UpdatedJun 18, 2026
Sendero Biotechnology

Sendero Biotechnology

Series A

Michigan-based software company and stealth-mode biotech firm, Sendero Biotechnology.

HQ
Rochester, MI, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded in partnership with Mayo Clinic, Sendero Biotechnology is a Michigan-based biotechnology company focused on developing novel oncology therapies. The company's core mission is to advance cancer treatment by targeting the TRAIL pathway, specifically through therapies against the immune evasion target TRAILshort. By leveraging cutting-edge research and technology licensed from Dr. Andrew Badley's lab, Sendero aims to bring innovative solutions to the oncology market.

Notable affiliations include the prestigious Mayo Clinic and Dr. Andrew Badley, whose research underpins the company's technological advancements. Although operating in stealth mode, Sendero Biotechnology has made significant strides in the field of cancer therapy. Its impact lies in its potential to revolutionize cancer treatment by addressing immune evasion mechanisms, thereby improving patient outcomes and advancing the broader field of oncology.

Sendero Biotechnology - Similar Companies

Seneca Therapeutics logo

Seneca Therapeutics

Exovita Biosciences logo

Exovita Biosciences

OncoResponse logo

OncoResponse

Sporos Bioventures logo

Sporos Bioventures

Senda Biosciences logo

Senda Biosciences

Novasenta logo

Novasenta

novasenta.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Trailhead Biosystems logo

Trailhead Biosystems

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Strm.Bio logo

Strm.Bio

strm.bio

Camino Pharma logo

Camino Pharma

caminopharma.com

Treadwell Therapeutics logo

Treadwell Therapeutics

treadwelltx.com

OncoTrap logo

OncoTrap

Sentien Biotechnologies logo

Sentien Biotechnologies

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Sendero Biotechnology - Quick Facts

Who are Sendero Biotechnology's competitors?

Companies similar to Sendero Biotechnology include Seneca Therapeutics, Exovita Biosciences, OncoResponse and Sporos Bioventures.

When was Sendero Biotechnology founded?

Sendero Biotechnology was founded in 2021.

Where is Sendero Biotechnology's headquarters located?

Sendero Biotechnology's headquarters is located in Rochester, MI, US.

When was Sendero Biotechnology's last funding round?

Sendero Biotechnology's most recent funding round was for $7.3M (USD) in April 2023.

How much has Sendero Biotechnology raised to-date?

As of Apr 28, 2023, Sendero Biotechnology has raised a total of $7.3M (USD).

How many employees does Sendero Biotechnology have?

Sendero Biotechnology has 50 employees as of Feb 5, 2024.

Sendero Biotechnology - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Therapies
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software